NO20091351L - Derivater av pyrrolizin, indolizin og quinolizin, fremstilling derav og terapeutisk anvendelse derav - Google Patents
Derivater av pyrrolizin, indolizin og quinolizin, fremstilling derav og terapeutisk anvendelse deravInfo
- Publication number
- NO20091351L NO20091351L NO20091351A NO20091351A NO20091351L NO 20091351 L NO20091351 L NO 20091351L NO 20091351 A NO20091351 A NO 20091351A NO 20091351 A NO20091351 A NO 20091351A NO 20091351 L NO20091351 L NO 20091351L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- pyridin
- therapeutic use
- pyrrolizine
- quinolizine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0608348A FR2906251B1 (fr) | 2006-09-22 | 2006-09-22 | Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique |
| PCT/FR2007/001545 WO2008037881A2 (fr) | 2006-09-22 | 2007-09-21 | Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20091351L true NO20091351L (no) | 2009-06-22 |
Family
ID=37897398
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20091351A NO20091351L (no) | 2006-09-22 | 2009-04-01 | Derivater av pyrrolizin, indolizin og quinolizin, fremstilling derav og terapeutisk anvendelse derav |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US7776880B2 (es) |
| EP (1) | EP2077837A2 (es) |
| JP (1) | JP2010504311A (es) |
| KR (1) | KR20090080947A (es) |
| CN (1) | CN101573113A (es) |
| AR (1) | AR062896A1 (es) |
| AU (1) | AU2007301880A1 (es) |
| BR (1) | BRPI0717100A2 (es) |
| CA (1) | CA2663080A1 (es) |
| CL (1) | CL2007002732A1 (es) |
| CO (1) | CO6160309A2 (es) |
| CR (1) | CR10658A (es) |
| EA (1) | EA015974B1 (es) |
| FR (1) | FR2906251B1 (es) |
| GT (1) | GT200900061A (es) |
| HN (1) | HN2009000504A (es) |
| IL (1) | IL197500A0 (es) |
| MA (1) | MA30790B1 (es) |
| ME (1) | MEP10109A (es) |
| MX (1) | MX2009003083A (es) |
| NO (1) | NO20091351L (es) |
| NZ (1) | NZ575573A (es) |
| PE (1) | PE20081376A1 (es) |
| SV (1) | SV2009003191A (es) |
| TN (1) | TN2009000082A1 (es) |
| TW (1) | TW200819455A (es) |
| UY (1) | UY30604A1 (es) |
| WO (1) | WO2008037881A2 (es) |
| ZA (1) | ZA200901850B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2842804B1 (fr) | 2002-07-29 | 2004-09-03 | Sanofi Synthelabo | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
| FR2861074B1 (fr) * | 2003-10-17 | 2006-04-07 | Sanofi Synthelabo | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
| UY32397A (es) * | 2009-01-28 | 2010-08-31 | Astrazeneca Ab | Compuestos de 2-aza-biciclo [2,2,1] heptano y sus usos |
| WO2010087761A1 (en) * | 2009-01-28 | 2010-08-05 | Astrazeneca Ab | 2-aza-bicyclo[2.2.2]octane compounds and uses thereof |
| US8338441B2 (en) | 2009-05-15 | 2012-12-25 | Gilead Sciences, Inc. | Inhibitors of human immunodeficiency virus replication |
| US8143273B2 (en) * | 2010-06-22 | 2012-03-27 | Hoffman-La Roche Inc. | Quinolizidine and indolizidine derivatives |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3801636A (en) * | 1971-08-13 | 1974-04-02 | Abbott Lab | 3,4,5-tri-substituted cinnamides |
| US4409225A (en) * | 1981-03-16 | 1983-10-11 | Beecham Group Limited | Substituted benzamides |
| US5552398A (en) * | 1991-09-12 | 1996-09-03 | Smithkline Beecham P.L.C. | Azabicyclic compounds as 5-HT4 receptor antagonists |
| CZ284456B6 (cs) | 1992-02-15 | 1998-12-16 | Hoechst Aktiengesellschaft | Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje |
| JP2004510712A (ja) * | 2000-09-22 | 2004-04-08 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | オクタヒドロ−インドリジンおよびキノリジンおよびヘキサヒドロ−ピロリジン |
| FR2861073B1 (fr) * | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
| FR2861076B1 (fr) * | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique |
-
2006
- 2006-09-22 FR FR0608348A patent/FR2906251B1/fr not_active Expired - Fee Related
-
2007
- 2007-09-13 TW TW096134256A patent/TW200819455A/zh unknown
- 2007-09-19 AR ARP070104135A patent/AR062896A1/es unknown
- 2007-09-20 PE PE2007001267A patent/PE20081376A1/es not_active Application Discontinuation
- 2007-09-21 KR KR1020097008124A patent/KR20090080947A/ko not_active Withdrawn
- 2007-09-21 BR BRPI0717100-5A patent/BRPI0717100A2/pt not_active IP Right Cessation
- 2007-09-21 MX MX2009003083A patent/MX2009003083A/es active IP Right Grant
- 2007-09-21 CL CL200702732A patent/CL2007002732A1/es unknown
- 2007-09-21 NZ NZ575573A patent/NZ575573A/en not_active IP Right Cessation
- 2007-09-21 UY UY30604A patent/UY30604A1/es not_active Application Discontinuation
- 2007-09-21 EA EA200970312A patent/EA015974B1/ru not_active IP Right Cessation
- 2007-09-21 AU AU2007301880A patent/AU2007301880A1/en not_active Abandoned
- 2007-09-21 CN CNA2007800392487A patent/CN101573113A/zh active Pending
- 2007-09-21 EP EP07848274A patent/EP2077837A2/fr not_active Withdrawn
- 2007-09-21 ME MEP-101/09A patent/MEP10109A/xx unknown
- 2007-09-21 JP JP2009528756A patent/JP2010504311A/ja not_active Withdrawn
- 2007-09-21 WO PCT/FR2007/001545 patent/WO2008037881A2/fr not_active Ceased
- 2007-09-21 ZA ZA200901850A patent/ZA200901850B/xx unknown
- 2007-09-21 CA CA002663080A patent/CA2663080A1/fr not_active Abandoned
-
2009
- 2009-03-09 IL IL197500A patent/IL197500A0/en unknown
- 2009-03-10 TN TN2009000082A patent/TN2009000082A1/fr unknown
- 2009-03-11 CR CR10658A patent/CR10658A/es not_active Application Discontinuation
- 2009-03-16 GT GT200900061A patent/GT200900061A/es unknown
- 2009-03-18 HN HN2009000504A patent/HN2009000504A/es unknown
- 2009-03-19 SV SV2009003191A patent/SV2009003191A/es active IP Right Grant
- 2009-03-19 CO CO09028765A patent/CO6160309A2/es unknown
- 2009-03-19 US US12/407,276 patent/US7776880B2/en not_active Expired - Fee Related
- 2009-04-01 NO NO20091351A patent/NO20091351L/no not_active Application Discontinuation
- 2009-04-16 MA MA31786A patent/MA30790B1/fr unknown
-
2010
- 2010-06-30 US US12/827,614 patent/US20100267766A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008037881A3 (fr) | 2008-05-22 |
| PE20081376A1 (es) | 2008-11-07 |
| NZ575573A (en) | 2011-12-22 |
| KR20090080947A (ko) | 2009-07-27 |
| AU2007301880A1 (en) | 2008-04-03 |
| MX2009003083A (es) | 2009-04-02 |
| US20090258899A1 (en) | 2009-10-15 |
| IL197500A0 (en) | 2009-12-24 |
| JP2010504311A (ja) | 2010-02-12 |
| ZA200901850B (en) | 2010-06-30 |
| TN2009000082A1 (en) | 2010-08-19 |
| FR2906251B1 (fr) | 2008-11-07 |
| US20100267766A1 (en) | 2010-10-21 |
| MEP10109A (en) | 2011-12-20 |
| CL2007002732A1 (es) | 2008-04-18 |
| UY30604A1 (es) | 2008-05-02 |
| CO6160309A2 (es) | 2010-05-20 |
| TW200819455A (en) | 2008-05-01 |
| EA015974B1 (ru) | 2012-01-30 |
| EA200970312A1 (ru) | 2009-12-30 |
| CA2663080A1 (fr) | 2008-04-03 |
| GT200900061A (es) | 2010-06-21 |
| US7776880B2 (en) | 2010-08-17 |
| SV2009003191A (es) | 2009-10-27 |
| WO2008037881A2 (fr) | 2008-04-03 |
| HN2009000504A (es) | 2011-10-20 |
| MA30790B1 (fr) | 2009-10-01 |
| CN101573113A (zh) | 2009-11-04 |
| BRPI0717100A2 (pt) | 2013-10-15 |
| FR2906251A1 (fr) | 2008-03-28 |
| AR062896A1 (es) | 2008-12-10 |
| EP2077837A2 (fr) | 2009-07-15 |
| CR10658A (es) | 2009-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20091351L (no) | Derivater av pyrrolizin, indolizin og quinolizin, fremstilling derav og terapeutisk anvendelse derav | |
| PE20090290A1 (es) | Derivados de pirrolopiridina como inhibidores de bace | |
| AR087328A1 (es) | Derivados de imidazo[1,2-b]piridazina e imidazo[4,5-b]piridina como inhibidores de jak | |
| NO20065573L (no) | Orto-substituerte aryl eller heteroarylamidforbindelser | |
| DK2327693T3 (da) | Indoler og terapeutisk anvendelse deraf | |
| JP2007508359A5 (es) | ||
| AR087755A1 (es) | Derivados de heterociclos biciclicos para el tratamiento de la hipertension arterial pulmonar | |
| AR082638A1 (es) | Derivados de tetrahidropiran utiles como pesticidas | |
| NO20065578L (no) | Substituerte metylaryl eller heteroarylamidforbindelser | |
| JP2009516646A5 (es) | ||
| NO20084129L (no) | Pyridin(3,4-B)Pyrazinoner | |
| EA201071112A1 (ru) | ПРОИЗВОДНЫЕ ПОЛИЗАМЕЩЁННЫХ 2-АРИЛ-6-ФЕНИЛИМИДАЗО[1,2-a]ПИРИДИНОВ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ ИХ В ТЕРАПИИ | |
| JP2009516697A5 (es) | ||
| HRP20120311T1 (en) | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | |
| JP2014509600A5 (es) | ||
| ATE510829T1 (de) | Neue verbindungen als adenosin-a1-rezeptor- antagonisten | |
| ECSP099441A (es) | Nuevos intermediarios y procesos útiles en la preparación de {2-[1-(3,5-bis-trifluorometil-bencil)-5-piridin-4-il-1h-[1,2,3]triazol-4-il]-piridin-3-il}-(2-clorofenil)-metanona | |
| JP2014516070A5 (es) | ||
| RU2014113974A (ru) | Замещенные бензиламины, их применение в медицине и, в частности, в лечении инфекций, вызванных вирусом гепатита с (hcv) | |
| AR117156A1 (es) | Compuestos meta-diamida para controlar plagas de invertebrados | |
| AR041968A1 (es) | Compuestos derivados de imidazol como ligandos del receptor de adenosina | |
| BRPI1009497A2 (pt) | Derivados de n-[(6-aza-biciclo[3.2.1] oct-5-il)-aril- metil]-heterobenzamida, o respectivo preparo e a respectiva aplicação em terapêutica | |
| JP2012512833A5 (es) | ||
| JP2008540333A5 (es) | ||
| RU2016101983A (ru) | Конденсированные пятичленные гетероциклические пиридиновые соединения, способ их производства и применение |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |